CDTX vs. MNPR

Last updated Jun 3, 2026

CDTX (Cidara Therapeutics, Inc.) and MNPR (Monopar Therapeutics Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. At a 0.11 correlation, their price movements are largely independent.

Performance

CDTX vs. MNPR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Cidara Therapeutics, Inc. (CDTX) and Monopar Therapeutics Inc. (MNPR). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

CDTX

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

MNPR

• 1D: -4.88%
• 1M: 15.04%
• YTD: -6.19%
• 6M: -19.33%
• 1Y: 104.13%
• 3Y*: 131.30%
• 5Y*: 15.66%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

CDTX vs. MNPR - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019
CDTX Cidara Therapeutics, Inc.	0.22%	721.76%	69.27%	4.98%	-40.45%	-36.50%	-47.92%	60.67%
MNPR Monopar Therapeutics Inc.	-6.19%	196.82%	1,193.36%	-85.65%	-26.17%	-47.55%	-63.13%	-37.36%

Correlation

The correlation between CDTX and MNPR is 0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.08
Correlation (3Y) Calculated over the trailing 3-year period	0.12
Correlation (5Y) Calculated over the trailing 5-year period	0.11
Correlation (All Time) Calculated using the full available price history since Dec 20, 2019	0.11

Fundamentals

Market Cap CDTX : $3.44B MNPR : $522.85M
EPS CDTX : -$11.88 MNPR : -$532.10
PB Ratio CDTX : 8.15 MNPR : 0.00
Total Revenue (TTM) CDTX : $0.00 MNPR : $0.00
Gross Profit (TTM) CDTX : -$45.00M MNPR : $0.00
EBITDA (TTM) CDTX : -$189.91M MNPR : -$5.24B

Return for Risk

CDTX vs. MNPR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MNPR

MNPR Risk / Return Rank: 73
MNPR Sharpe Ratio Rank: 77
MNPR Sortino Ratio Rank: 77
MNPR Omega Ratio Rank: 73
MNPR Calmar Ratio Rank: 72
MNPR Martin Ratio Rank: 66

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CDTX vs. MNPR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Cidara Therapeutics, Inc. (CDTX) and Monopar Therapeutics Inc. (MNPR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	CDTX	MNPR	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	1.30	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.05	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	-0.04	—

Drawdowns

Drawdown Indicators

	CDTX	MNPR	Difference
Max Drawdown Largest peak-to-trough decline	—	-98.93%	—
Max Drawdown (1Y) Largest decline over 1 year	—	-50.89%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-71.07%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-95.54%	—
Current Drawdown Current decline from peak	—	-54.62%	—
Average Drawdown Average peak-to-trough decline	—	-80.42%	—
Ulcer Index Depth and duration of drawdowns from previous peaks	—	30.43%	—

Volatility

Volatility by Period

	CDTX	MNPR	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	24.30%	—
Volatility (6M) Calculated over the trailing 6-month period	—	43.88%	—
Volatility (1Y) Calculated over the trailing 1-year period	—	80.97%	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	—	295.98%	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	—	265.06%	—

Dividends

CDTX vs. MNPR - Dividend Comparison

Neither CDTX nor MNPR has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both CDTX and MNPR in my portfolio?

CDTX and MNPR have a correlation of 0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.